[Article] [PubMed]10
The combined power of branched chain amino acids, digestive enzyme blend with L-glutamine, myoinositol, and d chiro inositol for women support with post-workout muscle recovery and easing discomfort
Exp Hematol Oncol
Areas of research interest Technical specifications Compound Information Copper-binding tripeptide complex Storage & Stability Lyophilized (powder) -20C long-term stable in sealed lyophilized form Reconstituted 2-8C use within 30 days of reconstitution Light Protect from light during storage and reconstitution Room temperature Short-term tolerant during shipping
This specialized approach helps restore optimal energy levels while supporting numerous bodily functions without digestive barriers, absorption issues, or the sugar crash that comes with energy drinks
This move positioned Roche to compete in the metabolic disease arena, leveraging Carmots small molecule platforms to diversify beyond oncology.[3] (2023): AstraZenecas Acquisition of CinCor Pharma Though primarily targeting hypertension, AstraZenecas US$1.8 billion buyout of CinCor included a nod toward combinational potential with metabolic therapies, signaling broader interest in cardiometabolic synergies.[4] (2024, 2025): Pfizers Strategic Reassessment and Potential for Acquisitions After halting internal development of its oral GLP-1 candidate due to tolerability concerns, Pfizer has publicly stated its interest in acquiring external GLP-1 assets
